[go: up one dir, main page]

MX2020005282A - Vector para la produccion de particulas aav. - Google Patents

Vector para la produccion de particulas aav.

Info

Publication number
MX2020005282A
MX2020005282A MX2020005282A MX2020005282A MX2020005282A MX 2020005282 A MX2020005282 A MX 2020005282A MX 2020005282 A MX2020005282 A MX 2020005282A MX 2020005282 A MX2020005282 A MX 2020005282A MX 2020005282 A MX2020005282 A MX 2020005282A
Authority
MX
Mexico
Prior art keywords
production
vector
aav particles
repgenes
nucleic acid
Prior art date
Application number
MX2020005282A
Other languages
English (en)
Inventor
Ryan Cawood
Alissa Sarah Bray
Thomas Augustus Payne
Original Assignee
Oxford Genetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61283699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020005282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oxford Genetics Ltd filed Critical Oxford Genetics Ltd
Publication of MX2020005282A publication Critical patent/MX2020005282A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a la produccion de plasmidos que son utiles en la produccion de particulas de virus adenoasociados (AAV). En particular, la invencion proporciona moleculas de acido nucleico que comprenden genes cap y genes rep, en donde los genes cap y rep se asocian ambos operativamente con el mismo promotor. La invencion proporciona, ademas, celulas huesped que comprenden moleculas de acido nucleico de la invencion y metodos para su uso.
MX2020005282A 2018-01-19 2019-01-18 Vector para la produccion de particulas aav. MX2020005282A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1800903.5A GB201800903D0 (en) 2018-01-19 2018-01-19 Vectors
PCT/GB2019/050134 WO2019141993A1 (en) 2018-01-19 2019-01-18 Vector for the production of aav particles

Publications (1)

Publication Number Publication Date
MX2020005282A true MX2020005282A (es) 2020-08-13

Family

ID=61283699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005282A MX2020005282A (es) 2018-01-19 2019-01-18 Vector para la produccion de particulas aav.

Country Status (12)

Country Link
US (1) US11697824B2 (es)
EP (1) EP3697917B1 (es)
JP (1) JP7140830B2 (es)
KR (1) KR102499953B1 (es)
CN (1) CN111511922B (es)
AU (1) AU2019208480B2 (es)
BR (1) BR112020010300A2 (es)
CA (1) CA3083376C (es)
GB (1) GB201800903D0 (es)
MX (1) MX2020005282A (es)
SG (1) SG11202004734UA (es)
WO (1) WO2019141993A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7105866B2 (ja) 2017-07-25 2022-07-25 オックスフォード ジェネティクス リミテッド アデノウイルスベクター
GB201800903D0 (en) 2018-01-19 2018-03-07 Oxford Genetics Ltd Vectors
GB201901571D0 (en) 2019-02-05 2019-03-27 Oxford Genetics Ltd Inducible AAV sysyem
KR20220137087A (ko) * 2020-02-04 2022-10-11 옥스포드 제네틱스 리미티드 아데노연관바이러스 벡터의 제조 방법
GB202001484D0 (en) * 2020-02-04 2020-03-18 Oxford Genetics Ltd DNA amplification method
EP4121521A4 (en) * 2020-03-17 2024-10-30 Biogen MA Inc. Methods and compositions for production of recombinant adeno-associated viruses
GB2599212A (en) 2020-07-30 2022-03-30 Shape Therapeutics Inc Stable cell lines for inducible production of rAAV virions
JP7670269B2 (ja) * 2021-01-14 2025-04-30 学校法人日本医科大学 不死化間葉系細胞を含む細胞集団を製造する方法及び不死化間葉系細胞を含む細胞集団
KR102685652B1 (ko) * 2021-05-27 2024-07-19 주식회사 뉴라클제네틱스 신규한 듀얼 헬퍼 플라스미드
US12305188B2 (en) 2021-05-27 2025-05-20 Neuracle Genetics Inc. Dual helper plasmid
WO2023060113A1 (en) * 2021-10-05 2023-04-13 Regenxbio Inc. Compositions and methods for recombinant aav production
CN118202060A (zh) * 2021-10-05 2024-06-14 再生生物股份有限公司 用于重组aav生产的组合物和方法
US12234472B2 (en) 2021-10-18 2025-02-25 Regeneron Pharmaceuticals, Inc. Eukaryotic cells comprising adenovirus-associated virus polynucleotides
WO2023086822A2 (en) * 2021-11-09 2023-05-19 Asimov Inc. Stable production systems for aav vector production
EP4502166A4 (en) * 2022-03-25 2025-09-24 Univ Jichi Medical EFFICIENT ADENO-ASSOCIATED VIRAL (AAV) VECTOR PRODUCTION SYSTEM
JPWO2023214579A1 (es) * 2022-05-02 2023-11-09
AU2023265204A1 (en) * 2022-05-02 2024-12-19 Synplogen Co., Ltd. Virus-derived construct plasmid library and construction of same
CN114657153A (zh) * 2022-05-24 2022-06-24 上海健士拜生物科技有限公司 rAAV重组包装质粒、用于rAAV包装的质粒系统和rAAV的制备方法
CN116064672B (zh) * 2022-09-15 2025-02-14 思鹏生物科技(苏州)有限公司 利用ires基因提升aav包装效率的方法及其功能基因
KR20250135175A (ko) * 2022-11-16 2025-09-12 포지 바이올로직스, 인크. 아데노바이러스 헬퍼 플라스미드
WO2024143440A1 (ja) 2022-12-28 2024-07-04 富士フイルム株式会社 アデノ随伴ウイルスの製造方法、およびベクターのセット
WO2024160232A1 (zh) * 2023-02-01 2024-08-08 纽福斯(苏州)生物科技有限公司 质粒包装系统及其应用
WO2025063664A1 (ko) * 2023-09-18 2025-03-27 삼성바이오에피스 주식회사 재조합 aav 생산을 위한 단일 벡터 시스템
EP4545643A1 (en) * 2023-10-23 2025-04-30 Sartorius Stedim Cellca GmbH Plasmids for improved aav titers and empty full ratios
WO2025087987A1 (en) * 2023-10-23 2025-05-01 Sartorius Stedim Cellca Gmbh Plasmids for improved aav titers and empty full ratios
WO2025217308A1 (en) * 2024-04-10 2025-10-16 Solid Biosciences Inc. Method of aav production

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622856A (en) 1995-08-03 1997-04-22 Avigen High efficiency helper system for AAV vector production
JP3881382B2 (ja) 1995-12-01 2007-02-14 イントロヘーネ ベスローテン フェンノートシャップ 安定にトランスフェクションされた哺乳類細胞における調節されたタンパク質発現
AU722375B2 (en) 1996-09-06 2000-08-03 Trustees Of The University Of Pennsylvania, The Methods using cre-lox for production of recombinant adeno-associated viruses
EP0856585A1 (en) 1997-01-29 1998-08-05 Introgene B.V. A conditional replication and expression system
WO1998046728A1 (en) 1997-04-14 1998-10-22 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant aav product
US6037177A (en) 1997-08-08 2000-03-14 Cell Genesys, Inc. Method for increasing the efficiency of recombinant AAV production
EP1015619A1 (en) 1997-09-19 2000-07-05 The Trustees Of The University Of Pennsylvania Methods and cell line useful for production of recombinant adeno-associated viruses
AU1269699A (en) * 1997-10-08 1999-04-27 Advanced Research And Technology Institute, Inc. Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
AU774706B2 (en) 1998-09-22 2004-07-08 Johns Hopkins University, The Methods for large-scale production of recombinant AAV vectors
US7115391B1 (en) 1999-10-01 2006-10-03 Genovo, Inc. Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
WO2001055361A2 (en) 2000-01-26 2001-08-02 Chiron Corporation Recombinant aav packaging systems
AU2002240890A1 (en) 2000-12-07 2002-06-18 Universite De Nantes Inducible highly productive raav packaging cell-lines
WO2002088346A2 (en) 2001-05-01 2002-11-07 National Research Council Of Canada A system for inducible expression in eukaryotic cells
CA2369985A1 (en) 2002-01-18 2003-07-18 Duke University Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
US20030225260A1 (en) 2002-04-30 2003-12-04 Snyder Richard O. Production of recombinant AAV virions
US20070202587A1 (en) 2002-09-23 2007-08-30 Applied Genetic Technologies Corporation Recombinant AAV production in mammalian cells
WO2006037215A1 (en) 2004-10-04 2006-04-13 National Research Council Of Canada Expression system, components thereof and methods of use
US20080044855A1 (en) 2006-03-22 2008-02-21 Yan Xu System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells
WO2007127264A2 (en) 2006-04-28 2007-11-08 The Trustees Of The University Of Pennsylvania Scalable production method for aav
WO2007148971A2 (en) * 2006-06-21 2007-12-27 Amsterdam Molecular Therapeutics B.V. Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
WO2008063802A2 (en) 2006-10-23 2008-05-29 University Of Florida Research Foundation, Inc. Suppression of mitochondrial oxidative stress
DK3093345T3 (da) 2007-07-26 2019-06-24 Uniqure Ip Bv Baculovirusvektorer omfattende gentagne kodende sekvenser med differentielle foretrukne kodoner
EP2553105B1 (en) * 2010-04-01 2014-12-17 Weidong Xiao Compositions and methods for the production of recombinant virus vectors
CN103189507A (zh) 2010-10-27 2013-07-03 学校法人自治医科大学 用于向神经系统细胞导入基因的腺相关病毒粒子
AU2015230094B2 (en) * 2014-03-10 2021-05-27 Uniqure Ip B.V. Further improved AAV vectors produced in insect cells
CN106544325B (zh) 2015-09-23 2018-09-07 中国科学院武汉物理与数学研究所 一种重组杆状病毒及其应用
GB201603577D0 (en) 2016-03-01 2016-04-13 Oxford Genetics Ltd Promoter
IL261665B2 (en) 2016-04-21 2023-11-01 Virovek Inc AVV production in insect cells, methods and preparations thereof
GB201706090D0 (en) 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Methods for adeno-associated viral vector production
CN110785495A (zh) * 2017-04-18 2020-02-11 葛兰素史克知识产权开发有限公司 腺相关病毒载体的生产方法
GB201800903D0 (en) 2018-01-19 2018-03-07 Oxford Genetics Ltd Vectors
GB201901571D0 (en) 2019-02-05 2019-03-27 Oxford Genetics Ltd Inducible AAV sysyem

Also Published As

Publication number Publication date
JP2021510496A (ja) 2021-04-30
CA3083376A1 (en) 2019-07-25
KR20200120613A (ko) 2020-10-21
US20210163987A1 (en) 2021-06-03
CN111511922A (zh) 2020-08-07
CA3083376C (en) 2022-09-20
BR112020010300A2 (pt) 2020-11-17
KR102499953B1 (ko) 2023-02-14
AU2019208480B2 (en) 2022-01-20
WO2019141993A1 (en) 2019-07-25
EP3697917A1 (en) 2020-08-26
AU2019208480A1 (en) 2020-07-16
SG11202004734UA (en) 2020-06-29
GB201800903D0 (en) 2018-03-07
US11697824B2 (en) 2023-07-11
CN111511922B (zh) 2023-06-09
EP3697917B1 (en) 2024-05-15
JP7140830B2 (ja) 2022-09-21

Similar Documents

Publication Publication Date Title
MX2020005282A (es) Vector para la produccion de particulas aav.
EP3597760A3 (en) Adeno-associated virus vector
BR112019001887A2 (pt) composições e métodos para o tratamento de doença associada a cep290
HK1252144A1 (zh) 提高原代細胞中基於核酸內切酶的基因編輯
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
EA201692206A1 (ru) Векторы на основе aav для генной терапии в сетчатке и cns
WO2017024317A3 (en) Methods to induce targeted protein degradation through bifunctional molecules
MX2018014152A (es) Composiciones y métodos para tratar la enfermedad de huntington.
MX2023012498A (es) Metodos escalables para producir vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspension libre de suero adecuado para su uso clinico.
EP3950941A3 (en) Dnase polypeptide variants
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
MX2022003116A (es) Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos.
AU2018260998A1 (en) Modulatory polynucleotides
SA520412637B1 (ar) B7 الفيروس الغدي الحال للورم المشفِّر لبروتين
MX391337B (es) Sistemas de replicón de arterivirus recombinantes y usos de estos.
EP4219702A3 (en) Enzyme variants and polynucleotides encoding the same
EA201792236A1 (ru) Получение увеличенных в размере векторов на основе аденоассоциированного вируса
MX2017014125A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
WO2016065349A8 (en) Short non-coding protein regulatory rnas (sprrnas) and methods of use
PH12018500155A1 (en) Recombinant orf virus vector
MY205041A (en) Variant rnai
EP3964575A3 (en) Alpha-amylase variants and polynucleotides encoding same
EP4357453A3 (en) Lipase variants, polynucleotides encoding same and the use thereof
BR112018009732A8 (pt) ?polinucleotídeo, vetor de vírus adeno-associado, partícula de vírus adeno-associado, célula hospedeira, métodos para produzir uma partícula de vírus adeno-associado, para tratar hemofilia a, para transduzir uma célula hospedeira, e, uso de uma partícula de vírus adeno-associado?
EP3739045A3 (en) Cellobiohydrolase variants and polynucleotides encoding same